The radiation therapy market would grow at a CAGR of 7.65% over the predicted time frame. The market is expected to increase in value from US$ 7.32 Bn in 2022 to US$ 13.2 Bn in 2030.

Key Takeaways:

• North America has accounted revenue share of around 38.7% in 2021.
• APAC is expected to reach at a CAGR of 7.6% from 2022 to 2030
• By type, the external beam therapy has captured market share of 81%.
• By application, the breast cancer segment has contributed highest market share in 2021.
• By end-users, hospitals segment held highest revenue share 72% in 2021.

The on radiation therapy Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2272

A recent report provides crucial insights along with application based and forecast information in the Global Radiation therapy Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Radiation therapy market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific Revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Radiation therapy market are included as given below:

Radiation therapy Market Key Players are: Nordion Inc, Siemens healthcare, Mevion medical system, Inc, Isoray, Inc, Icad, Inc, Becton Dickinson and Company, Ion Beam Appications SA, Elekta AB, Eckert & Zeigler Group, Accuray, Incorporated, Varian Medical Syatems, Inc, NTP Radioisotopes SOC Ltd, Curium Pharma, C.R.BARD, Inc, IBA Radiopharma Solutions, ViewRay, Inc, P-cure Ltd, ZEISS Group, Panacea Medical Technologies, Hitachi Ltd

Market Segments

By Type

• Product
• Service

By Technology

• External Beam Radiotherapy
  • Linear accelerators
    • Convential linear accelerators 
    • Stereotactic advanced Elecron/Cobalt-60-linear accelerators 
    • Gamma Knife
    • CyberKnife
    • Tomotherapy
• Convnetial Cobalt-60 Teletherapy Units
• Particle Therapy Systems
  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotron
• Internal Beam Radiotherapy/Brachytherapy
  • Seeds
  • Afterloaders
  • Applicators
  • IORT Systems
• Systemic Radiotherapy
  • Lobenguane (I-131)
  • Samarium-153
  • Rhenium- 186
  • Others

By Application

• External Beam Radiotherapy
  • Prostate cancer
  • Breast cancer
  • Lung cancer
  • Head and neck cancer
  • Colorectal cancer
  • Others
• Internal Beam Radiotherapy/Brachytherapy
  • Prostate cancer
  • Gynecological cancer
  • Breast cancer
  • Cervical cancer
  • Penile cancer
  • Others

By Procedure

• External Beam Radiotherapy
  • Image guided radiotherapy
  • Intensity-modulated radiotherapy
  • Stereotactic therapy
  • Particle therapy
  • 3D Conformal radiotherapy
• Internal Beam Radiotherapy/Brachytherapy
  • High-dose-rate Brachytherapy
  • Low-dose-rate Brachytherapy
  • Pulsed-dose-rate Brachytherapy
• Systemic Radiotherapy
• Intravenouos Radiotherapy
• Oral Radiotherapy
• Instillation Radiotherapy

By End-User

• Hospitals
• Independent Radiotherapy Centers

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Report Objectives

• To define, describe, and forecast the global radiation therapy market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the radiation therapy market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Radiation Therapy Market 

5.1. COVID-19 Landscape: Radiation Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Radiation Therapy Market, By Type

8.1. Radiation Therapy Market, by Type, 2022-2030

8.1.1. Product

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Service

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Radiation Therapy Market, By Technology

9.1. Radiation Therapy Market, by Technology, 2022-2030

9.1.1. External Beam Radiotherapy

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Convnetial Cobalt-60 Teletherapy Units

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Particle Therapy Systems

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Internal Beam Radiotherapy/Brachytherapy

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Systemic Radiotherapy

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Radiation Therapy Market, By Application 

10.1. Radiation Therapy Market, by Application, 2022-2030

10.1.1. External Beam Radiotherapy

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Internal Beam Radiotherapy/Brachytherapy

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Radiation Therapy Market, By Procedure

11.1. Radiation Therapy Market, by Procedure, 2022-2030

11.1.1. External Beam Radiotherapy

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Internal Beam Radiotherapy/Brachytherapy

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Systemic Radiotherapy

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Intravenouos Radiotherapy

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Oral Radiotherapy

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Instillation Radiotherapy

11.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Radiation Therapy Market, By End-User

12.1. Radiation Therapy Market, by End-User, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Independent Radiotherapy Centers

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Radiation Therapy Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.5. Market Revenue and Forecast, by End-User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End-User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.4. Market Revenue and Forecast, by Procedure (2017-2030) 

13.2.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.7. Market Revenue and Forecast, by Procedure (2017-2030) 

13.2.8. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.10. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.11. Market Revenue and Forecast, by End-User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.13. Market Revenue and Forecast, by End-User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.15. Market Revenue and Forecast, by End-User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.7. Market Revenue and Forecast, by End-User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.9. Market Revenue and Forecast, by End-User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.7. Market Revenue and Forecast, by End-User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.9. Market Revenue and Forecast, by End-User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.7. Market Revenue and Forecast, by End-User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 14. Company Profiles

14.1. Nordion Inc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Siemens healthcare

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Mevion medical system, Inc

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Isoray, Inc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Icad, Inc

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Becton Dickinson and Company

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Ion Beam Appications SA

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Elekta AB

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Eckert & Zeigler Group

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Accuray

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: [email protected]

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com